Company news

Rallybio Corporation news in 2026

Rallybio Corporation's news releases, calls and decks from 2026, newest first.

View company

Rallybio Corporation and Avenzo Therapeutics Announce Merger Agreement to Advance Next-Generation Oncology Therapies and $215 Million Concurrent Private Placement

May 31, 2026

Rallybio Corporation and Candid Therapeutics Announce Merger Agreement

March 1, 2026

Rallybio Announces Positive Data for RLYB116 Phase 1 Study Demonstrating Complete and Sustained Inhibition of Terminal Complement

February 17, 2026

Rallybio Announces Reverse Stock Split of Common Stock

February 3, 2026

Decks in 2026